Clearfield director receives 326-share equity grant with one-year vest
Clearfield, Inc. reported that one of its directors acquired 326 shares of its common stock on 12/10/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Clearfield, Inc. reported that one of its directors acquired 326 shares of its common stock on 12/10/2025. The shares were acquired at a stated price of $0, indicating they were granted as equity compensation rather than bought in the market. After this grant, the director beneficially owns 326 shares directly. The restrictions on these shares lapse on the one-year anniversary of the grant date, so the stock becomes fully available only after that vesting period.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 326 | $0.00 | $0.00 |
Footnotes (1)
- F1. The restrictions on the shares lapse on the one year anniversary of the date of the grant.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Clearfield, Inc. (CLFD) disclose in this report?
Clearfield, Inc. disclosed that a director received 326 shares of common stock as an equity grant on 12/10/2025, reported as an acquisition.
What is the director’s beneficial ownership in Clearfield (CLFD) after this transaction?
Following the reported transaction, the director beneficially owns 326 shares of Clearfield common stock, held as direct ownership.
Is this Clearfield (CLFD) insider filing for one person or multiple reporting persons?
The report indicates that the form is filed by one reporting person, not by a group.
AI-generated analysis. How Rhea-AI works. Not financial advice.